- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting CTCFL/BORIS for the immunotherapy of cancer
Authors
Keywords
-
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 67, Issue 12, Pages 1955-1965
Publisher
Springer Nature America, Inc
Online
2018-11-02
DOI
10.1007/s00262-018-2251-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is a novel target of lung cancer stem-like cell immunotherapy
- (2017) Ryota Horibe et al. PLoS One
- The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non‐coding RNA and synonymous mutations
- (2016) Sven Diederichs et al. EMBO Molecular Medicine
- The cancer-associated CTCFL/BORIS protein targets multiple classes of genomic repeats, with a distinct binding and functional preference for humanoid-specific SVA transposable elements
- (2016) Elena M. Pugacheva et al. Epigenetics & Chromatin
- Systematic identification of genes with a cancer-testis expression pattern in 19 cancer types
- (2016) Cheng Wang et al. Nature Communications
- Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy
- (2016) Takuya Asano et al. Oncotarget
- Expression of theCTCFLGene during Mouse Embryogenesis Causes Growth Retardation, Postnatal Lethality, and Dysregulation of the Transforming Growth Factor β Pathway
- (2015) Leyla Sati et al. MOLECULAR AND CELLULAR BIOLOGY
- The p53 family and the hypoxia-inducible factors (HIFs): determinants of cancer progression
- (2015) Ivano Amelio et al. TRENDS IN BIOCHEMICAL SCIENCES
- Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells
- (2015) Loredana Alberti et al. PLoS One
- p16INK4Aand p14ARFGene Promoter Hypermethylation as Prognostic Biomarker in Oral and Oropharyngeal Squamous Cell Carcinoma: A Review
- (2014) A. Al-Kaabi et al. DISEASE MARKERS
- X-chromosome inactivation in development and cancer
- (2014) Ronan Chaligné et al. FEBS LETTERS
- High Expression of hTERT and Stemness Genes in BORIS/CTCFL Positive Cells Isolated from Embryonic Cancer Cells
- (2014) Loredana Alberti et al. PLoS One
- The long-range interaction landscape of gene promoters
- (2012) Amartya Sanyal et al. NATURE
- Topological domains in mammalian genomes identified by analysis of chromatin interactions
- (2012) Jesse R. Dixon et al. NATURE
- The p53 network: cellular and systemic DNA damage responses in aging and cancer
- (2012) H. Christian Reinhardt et al. TRENDS IN GENETICS
- The male germ cell gene regulator CTCFL is functionally different from CTCF and binds CTCF-like consensus sites in a nucleosome composition-dependent manner
- (2012) Frank Sleutels et al. Epigenetics & Chromatin
- Cancer-testis antigen, BORIS based vaccine delivered by dendritic cells is extremely effective against a very aggressive and highly metastatic mouse mammary carcinoma
- (2011) Mikayel Mkrtichyan et al. CELLULAR IMMUNOLOGY
- Molecular mechanisms of genomic imprinting and clinical implications for cancer
- (2011) Santiago Uribe-Lewis et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Expression of the Epigenetic factor BORIS (CTCFL) in the Human Genome
- (2011) Rosalia de Necochea-Campion et al. Journal of Translational Medicine
- Widespread Expression of BORIS/CTCFL in Normal and Cancer Cells
- (2011) Tania A. Jones et al. PLoS One
- Functional Analysis of CTCF During Mammalian Limb Development
- (2010) Natalia Soshnikova et al. DEVELOPMENTAL CELL
- Expression of a Testis-Specific Form of Gal3st1 (CST), a Gene Essential for Spermatogenesis, Is Regulated by the CTCF Paralogous Gene BORIS
- (2010) T. Suzuki et al. MOLECULAR AND CELLULAR BIOLOGY
- BORIS (CTCFL) Is Not Expressed in Most Human Breast Cell Lines and High Grade Breast Carcinomas
- (2010) William C. Hines et al. PLoS One
- The Structural Complexity of the Human BORIS Gene in Gametogenesis and Cancer
- (2010) Elena M. Pugacheva et al. PLoS One
- CTCF: Master Weaver of the Genome
- (2009) Jennifer E. Phillips et al. CELL
- Coordinated Activation of Candidate Proto-Oncogenes and Cancer Testes Antigens via Promoter Demethylation in Head and Neck Cancer and Lung Cancer
- (2009) Ian M. Smith et al. PLoS One
- BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumours
- (2008) V D'Arcy et al. BRITISH JOURNAL OF CANCER
- CTCF regulates cell cycle progression of αβ T cells in the thymus
- (2008) Helen Heath et al. EMBO JOURNAL
- Global analysis of the insulator binding protein CTCF in chromatin barrier regions reveals demarcation of active and repressive domains
- (2008) S. Cuddapah et al. GENOME RESEARCH
- The Evolution of Epigenetic Regulators CTCF and BORIS/CTCFL in Amniotes
- (2008) Timothy A. Hore et al. PLoS Genetics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now